1.      Yoshiya, T., Mimae, T., Ito, M., Sasada, S., Tsutani, Y., Satoh, K., Masuda, T., Miyata, Y., Hattori, N., Okada, M.: Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy. Invest New Drugs. 2020 Apr;38(2):485-492. 

2.      Mimae, T., Okada, M.: Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer? Gen Thorac Cardiovasc Surg. 2020 Jul;68(7):703-706. 

3.      Makidono, K., Miyata, Y., Ikeda, T., Tsutani, Y., Kushitani, K., Takeshima, Y., Okada M.: Investigation of surgical technique for bronchial stump closure after lobectomy in animal model. Gen Thorac Cardiovasc Surg. 2020 Jun;68(6):609-614. 

4.      Ohsawa, M., Tsutani, Y., Fujiwara, M., Mimae, T., Miyata, Y., Okada, M.: Predicting Severe Postoperative Complication in Patients with Lung Cancer and Interstitial Pneumonia. Ann Thorac Surg. 2020 Apr;109(4):1054-1060. 

5.      Handa, Y., Tsutani, Y., Shiroma, N., Kai, Y., Mimae, T., Miyata, Y., Takeshima, Y., Arihiro, K., Okada, M.: Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer. Clin Lung Cancer. 2020 Jul;21(4):e302-e314. 

6.      Kagimoto, A., Tsutani, Y., Izaki, Y., Handa, Y., Mimae, T., Miyata, Y., Okada, M.: Initial experience of robotic anatomical segmentectomy for non-small cell lung cancer. Jpn J Clin Oncol. 2020 Apr 7;50(4):440-445.

7.      Shimizu, H., Okada, M., Tangoku, A., Doki, Y., Endo, S., Fukuda, H., Hirata, Y., Iwata, H., Kobayashi, J., Kumamaru, H., Miyata, H., Motomura, N., Natsugoe, S., Ozawa, S., Saiki, Y., Saito, A., Saji, H., Sato, Y., Taketani, T., Tanemoto, K., Tatsuishi, W., Toh, Y., Tsukihara, H., Watanabe, M., Yamamoto, H., Yokoi, K., Okita, Y.: Thoracic and cardiovascular surgeries in Japan during 2017 : Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2020 Apr;68(4):414-449.

8.      Sakane, H., Ishida, M., Shi, L., Fukumoto, W., Sakai, C., Miyata, Y., Ishida, T., Akita, T., Okada, M., Awai, K., Tashiro, S.: Biological Effects of Low-Dose Chest CT on Chromosomal DNA. Radiology. 2020 May;295(2):439-445. 

9.      Koi, Y., Tsutani, Y., Nishiyama, Y., Ueda, D., Ibuki, Y., Sasada, S., Akita, T., Masumoto, N., Kadoya, T., Yamamoto, Y., Takahashi, RU., Tanaka, J., Okada, M., Tahara, H.: Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles. Cancer Sci. 2020 Jun;111(6):2104-2115.

10.   Koi, Y., Tsutani, Y., Nishiyama, Y., Kanda, M., Shiroma, Y., Yamamoto, Y., Sasada, S., Akita, T., Masumoto, N., Kadoya, T., Takahashi, RU., Tanaka, J., Okada, M., Tahara, H.: Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer. Cancer Sci. 2020 May;111(5):1856-1861.

11.   Ibuki, Y., Nishiyama, Y., Tsutani, Y., Emi, M., Hamai, Y., Okada, M., Tahara, H.: Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma. PLoS One. 2020 Apr 6;15(4):e0231116. doi: 10.1371/journal.pone.0231116. eCollection 2020.

12.   Kagimoto, A., Tsutani, Y., Izaki, Y., Handa, Y., Mimae, T., Miyata, Y., Okada, M.: Prediction of lymph node metastasis using semiquantitative evaluation of PET for lung adenocarcinoma. Ann Thorac Surg. 2020 Apr 14:S0003-4975(20)30546-4.

13.   Hamai, Y., Emi, M., Ibuki, Y., Murakami, Y., Nishibuchi, I., Nagata, Y., Furukawa, T., Kurokawa, T., Ohsawa, M., Yoshikawa, T., Okada, M.: Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma After Trimodal Therapy. Ann Surg Oncol. 2020 Oct;27(11):4422-4430. 

14.   Kamigaichi, A., Tsutani, Y., Kagimoto, A., Fujiwara, M., Mimae, T., Miyata, Y., Okada, M.: Comparing Segmentectomy and Lobectomy for Clinical Stage IA Solid-dominant Lung Cancer Measuring 2.1 to 3 cm. Clin Lung Cancer. 2020 Nov;21(6):e528-e538.

15.   Sasada, S., Kimura, Y., Emi, A., Masumoto, N., Kadoya, T., Arihiro, K., Okada, M.: Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer. Anticancer Res. 2020 Jun;40(6):3395-3400. 

16.   Sasada, S., Masumoto, N., Kimura, Y., Emi, A., Kadoya, T., Okada, M.: Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer. Anticancer Res. 2020 Jun;40(6):3491-3497. 

17.   Kambara, T., Amatya, VJ., Kushitani, K., Suzuki, R., Fujii, Y., Kai, Y., Miyata, Y., Okada, M., Takeshima, Y.: SOX6 Is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma. Am J Surg Pathol. 2020 Sep;44(9):1259-1265.

18.   Tanaka, K., Tsutani, Y., Wakabayashi, M., Mizutani, T., Aokage, K., Miyata, Y., Kuroda, H., Saji, H., Watanabe, SI., Okada, M; behalf of the Lung Cancer Surgical Study Group/Japan Clinical Oncology Group. : Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE). Jpn J Clin Oncol. 2020 Sep 5;50(9):1076-1079.

19.   Mimae, T., Miyata, Y., Tsutani, Y., Imai, K., Ito, H., Nakayama, H., Ikeda, N., Okada, M.: Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small-cell lung cancer. Jpn J Clin Oncol. 2020 Sep 5;50(9):1051-1057. 

20.   Sridhar, P., Litle, VR., Okada, M., Suzuki, K.: Prevention of Postoperative Prolonged Air Leak After Pulmonary Resection. Thorac Surg Clin. 2020 Aug;30(3):305-314. 

21.   Ohsawa, M., Hamai, Y., Ibuki, Y., Emi, M., Okada, M.: Successful Management of Esophageal Cancer With Perforation Using Bypass Surgery Followed by Definitive Chemoradiotherapy. In Vivo. 2020 Jul-Aug;34(4):2169-2172.

22.   Tsutani, Y., Nakayama, H., Ito, H., Handa, Y., Mimae, T., Miyata, Y., Okada, M.: Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [ 18 F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography. Clin Lung Cancer. 2020 Jun 19:S1525-7304(20)30207-2. doi: 10.1016/j.cllc.2020.06.013. Online ahead of print.

23.   Kurokawa, T., Hamai, Y., Emi, M., Ibuki, Y., Yoshikawa, T., Ohsawa, M., Hirohata, R., Okada, M.: Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy. Anticancer Res. 2020 Aug;40(8):4387-4394.

24.   Handa, Y., Tsutani, Y., Mimae, T., Miyata, Y., Imai, K., Ito, H., Nakayama, H., Ikeda, N., Yoshimura, K., Okada, M.: Oncologic outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis. Ann Thorac Surg. 2021 Mar;111(3):1044-1051. 

25.   Hamai, Y., Emi, M., Ibuki, Y., Kurokawa, T., Yoshikawa, T., Ohsawa, M., Hirohata, R., Murakami, Y., Nishibuchi, I., Imano, N., Nagata, Y., Okada, M.: Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy. Ann Surg Oncol. 2021 Mar;28(3):1798-1807.

26.   Kamigaichi, A., Tsutani, Y., Mimae, T., Miyata, Y., Ito, H., Nakayama, H., Ikeda, N., Okada, M.: Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer. Eur J Cardiothorac Surg. 2020 Dec 1;58(6):1245-1253. 

27.   Kagimoto, A., Tsutani, Y., Handa, Y., Mimae, T., Miyata, Y., Okada, M.: Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm. Jpn J Clin Oncol. 2020 Oct 22;50(11):1306-1312.

28.   Johnston, SRD., Harbeck, N., Hegg, R., Toi, M., Martin, M., Shao, ZM., Zhang, QY., Martinez, Rodriguez, JL., Campone, M., Hamilton, E., Sohn, J., Guarneri, V., Okada, M., Boyle, F., Neven, P., Cortés, J., Huober, J., Wardley, A., Tolaney, SM., Cicin, I., Smith, IC., Frenzel, M., Headley, D., Wei, R., San, Antonio, B., Hulstijn, M., Cox, J., O'Shaughnessy, J., Rastogi, P; monarchE Committee Members and Investigators. : Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE). J Clin Oncol. 2020 Dec 1;38(34):3987-3998. 

29.   Kagimoto, A., Tsutani, Y., Handa, Y., Mimae, T., Miyata, Y., Okada, M.: Prediction of acute exacerbation of interstitial pneumonia using visual evaluation of PET. Ann Thorac Surg. 2020 Oct 12:S0003-4975(20)31669-6. doi: 10.1016/j.athoracsur.2020.08.018. Online ahead of print.

30.   Sasada, S., Masumoto, N., Song, H., Emi, A., Kadoya, T., Arihiro, K., Kikkawa, T., Okada, M.: Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study. JMIR Res Protoc. 2020 Oct 19;9(10):e17524. 

31.   Kenmotsu, H., Niho, S., Tsuboi, M., Wakabayashi, M., Ishii, G., Nakagawa, K., Daga, H., Tanaka, H., Saito, H., Aokage, K., Takahashi, T., Menju, T., Kasai, T., Yoshino, I., Minato, K., Okada, M., Eba, J., Asamura, H., Ohe, Y., Watanabe, SI.: Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206. J Clin Oncol. 2020 Dec 20;38(36):4292-4301. 

32.   Kagimoto, A., Tsutani, Y., Kushitani, K., Kai, Y., Kambara, T., Miyata, Y., Takeshima, Y., Okada, M.: Segmentectomy vs. lobectomy for clinical stage IA lung adenocarcinoma with spread through air spaces. Ann Thorac Surg. 2020 Oct 31:S0003-4975(20)31820-8. doi: 10.1016/j.athoracsur.2020.09.020. Online ahead of print.

33.   Kimura, Y., Sasada, S., Emi, A., Masumoto, N., Kadoya, T., Okada, M.: Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer. Support Care Cancer. 2020 Nov 4. doi: 10.1007/s00520-020-05868-1. Online ahead of print.

34.   Yotsukura, M., Nakagawa, K., Suzuki, K., Takamochi, K., Ito, H., Okami, J., Aokage, K., Shiono, S., Yoshioka, H., Aoki, T., Tsutani, Y., Okada. M., Watanabe, SI; Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG).: Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer. Jpn J Clin Oncol. 2021 Jan 1;51(1):28-36.

35.   Takahashi, M., Kato, K., Okada, M., Chin, K., Kadowaki, S., Hamamoto, Y., Doki, Y., Kubota, Y., Kawakami, H., Ogata, T., Hara, H., Muto, M., Nakashima, Y., Ishihara, R., Tsuda, M., Motoyama, S., Kodani, M., Kitagawa, Y.: Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3). Esophagus. 2021 Jan;18(1):90-99.

36.   Handa, Y., Tsutani, Y., Mimae, T., Miyata, Y., Ito, H., Nakayama, H., Ikeda, N., Okada, M.: Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study. Jpn J Clin Oncol. 2021 Mar 3;51(3):451-458.

37.   Tsutani, Y., Handa, Y., Shimada, Y., Ito, H., Ikeda, N., Nakayama, H., Yoshimura, K., Okada, M.: Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 Oct 22:S0022-5223(20)32833-6. doi: 10.1016/j.jtcvs.2020.10.024. Online ahead of print.

38.   Shimizu, K., Ohtaki, Y., Suzuki, K., Date, H., Yamashita, M., Iizasa, T., Ito, H., Yoshimura, K., Okada, M., Chida. M.; Japanese Association for Chest Surgery. Salvage surgery for non-small-cell lung cancer after definitive radiotherapy.: Ann Thorac Surg. 2020 Nov 26:S0003-4975(20)32021-X. doi: 10.1016/j.athoracsur.2020.10.035. Online ahead of print.

39.   Handa, Y., Tsutani, Y., Mimae, T., Miyata, Y., Okada, M.: Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection. Clin Lung Cancer. 2021 Mar;22(2):e224-e233..

40.   Ochi, M., Murakami, Y., Nishibuchi, I., Kubo, K., Imano, N., Takeuchi, Y., Kimura, T., Hamai, Y., Emi, M., Okada, M., Nagata, Y.: Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma. J Radiat Res. 2021 Jan 1;62(1):142-148.

41.   Ohtaki, Y., Shimizu, K., Suzuki, H., Suzuki, K., Tsuboi, M., Mitsudomi, T., Takao, M., Murakawa, T., Ito, H., Yoshimura, K., Okada, M., Chida, M; Japanese Association for Chest Surgery. : Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment. Lung Cancer. 2021 Mar;153:108-116.

42.   Kamigaichi, A., Tsutani, Y., Mimae, T., Miyata, Y., Shimada, Y., Ito, H., Nakayama, H., Ikeda, N., Okada, M.: Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2021 Mar;22(2):120-126.

43.   Yamaguchi, M., Nakagawa, K., Suzuki, K., Takamochi, K., Ito, H., Okami, J., Aokage, K., Shiono, S., Yoshioka, H., Aoki, T., Tsutani, Y., Okada, M., Watanabe SI; Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG). : Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer. Jpn J Clin Oncol. 2021 Mar 3;51(3):333-344.

44.   Miyazaki, T., Fukuchi, E., Yamamoto, H., Miyata, H., Tanaka, F., Okada, M., Suzuki, K., Yoshino, I., Endo, S., Sato, Y., Chida, M., Nagayasu, T.: Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection. Surg Today. 2021 Jan 30. doi: 10.1007/s00595-021-02227-3. Online ahead of print.

45.   Makidono, K., Miyata, Y., Ikeda, T., Tsutani, Y., Kai, Y., Kushitani, K., Takeshima, Y., Okada, M.: Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report. J Med Case Rep. 2021 Feb 18;15(1):71. doi: 10.1186/s13256-020-02652-x.

46.   Tanaka, Y., Yamamoto, H., Sato, M., Toyooka, S., Okada, M., Endo, S., Sato, Y., Suzuki, K., Maniwa, Y., Fukuchi, E., Miyata, H., Chida, M.: Preoperative cumulative smoking dose on lung cancer surgery in a Japanese nationwide database. Ann Thorac Surg. 2021 Feb 15:S0003-4975(21)00281-2. doi: 10.1016/j.athoracsur.2021.01.055. Online ahead of print.

47.   Shibaki, R., Akamatsu, H., Kato, T., Nishino, K., Okada, M., Mitsudomi, T., Wakuda, K., Yoshimura, K., Yamamoto, N., Nakagawa, K.: A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study). Ther Adv Med Oncol. 2021 Jan 21;13:1758835920987647. doi: 10.1177/1758835920987647. eCollection 2021.

48.   Sasada, S., Kimura, Y., Masumoto, N., Emi, A., Kadoya, T., Arihiro, K., Okada, M.: Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors. Eur J Surg Oncol. 2021 Mar 3:S0748-7983(21)00117-7. doi: 10.1016/j.ejso.2021.02.026. Online ahead of print.

49.   Kai, Y., Amatya, VJ., Kushitani, K., Kambara, T., Suzuki, R., Fujii, Y., Tsutani, Y., Miyata, Y., Okada, M., Takeshima, Y.: Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung. Transl Lung Cancer Res. 2021 Feb;10(2):766-775.

50.   Kagimoto, A., Tsutani, Y., Mimae, T., Miyata, Y., Ikeda, N., Ito, H., Maniwa, Y., Suzuki, K., Tsuboi, M., Yoshimura, K., Umemoto, S., Okada, M.: 4 Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL). BMJ Open. 2021 Mar 17;11(3):e043234. doi: 10.1136/bmjopen-2020-043234.

51.   Sasada, S., Masumoto, N., Emi, A., Kadoya, T., Arihiro, K., Okada, M.: Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis. Breast Cancer. 2021 Mar 19. doi: 10.1007/s12282-021-01236-x. Online ahead of print.

52.   Mimae, T., Saji, H., Okada, M.: ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy? Ann Surg Oncol. 2021 Mar 23. doi: 10.1245/s10434-021-09860-9. Online ahead of print.

53.   Taguchi, S., Saeki, N., Morio, A., Nakamura, R., Kamiya, S., Ikeda, T., Oshita, K., Hamada, H., Miyata, Y., Okada, M., Tsutsumi, YM.: Novel technique for identification of the pulmonary intersegmental plane using manual jet ventilation during pulmonary segmentectomy. Wideochir Inne Tech Maloinwazyjne. 2021 Mar;16(1):169-174.

54.   Ishiguro, H., Masuda, N., Sato, N., Higaki, K., Morimoto, T., Yanagita, Y., Mizutani, M., Ohtani, S., Kaneko, K., Fujisawa, T., Takahashi, M., Kadoya, T., Matsunami, N., Yamamoto, Y., Ohno, S., Takano, T., Morita, S., Tanaka-Mizuno, S., Toi, M.: A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer. Breast Cancer Rcs Treat .2020;180(3):715-724

55.   Yamashita, T., Masuda, N., Saji, S., Araki, K., Ito, Y., Takano, T., Takahashi, M., Tsurutani, J., Koizumi, K., Kitada, M., Kojima, Y., Sagara, Y., Tada, H., Iwasa, T., Kadoya, T., Iwatani, T., Hasegawa, H., Morita, S., Ohno, S.: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD). Trials. 2020 May 7;2181):391. doi:10.1186/s13063-020-04341-y.

56.   Kubo, M., Kumamaru, H., Isozumi, U., Miyashita, M., Nagahashi, M., Kadoya, T., Kojima, Y., Aogi, K., Hayashi, N., Tamura, K., Asaga, S., Niikura, N., Ogo, E., Iijima, K., Tanakura, K., Yoshida, M., Miyata, H., Yamamoto, Y., Imoto, S., Jinno, H.: Annual report of the Japanese Breast Cancer Society registry for 2016. Breast Cancer. 2020 Jul;27(4):511-518. doi : 10.1007/ s1228-020-01081-4. Epub 2020 May 11.

57.   Hayashi, N., Kumamaru, H., Isozumi, U., Aogi, K., Asaga, S., Iijima, K,. Kadoya, T., Kojima, Y., Kubo, M., Miyashita, M., Miyata, H., Nagahashi, M., Niikura, N., Ogo, E., Tamura, K., Tanakura, K., Yamamoto, Y., Yoshida, M., Imoto, S., Jinno, H.: Annual report of the Japanese Breast Cancer Society registry for 2017. Breast Cancer. 2020 Sep;27(5):803-809.doi:10. 1007/s12282-020-01139-3. Epub 2020 Jul 24.

58.   Tanaka, K., Masuda, N., Hayashi, N., Sagara, Y., Hara, F., Kadoya, T., Matsui, A., Miyazaki, C., Shien, T., Tokunaga, E., Hayashi, T., Niikura, N., Maeda, S., Komoike, Y., Bando, H., Kanbayashi, C., Iwata, H.: Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study. Breast Cancer. 2021 Feb 18.doi:10.1007/s12282-021-01225-0. Online ahead of print.

59.   Masuda, N., Bando, H., Yamanaka, T., Kadoya, T., Takahashi, M., Nagai, SE., Ohtani, S., Aruga, T., Suzuki, E., Kikawa, Y., Yasojima, H., Kasai, H., Ishiguro, H., Kawabata, H., Morita, S., Haga, H., Kataoka, TR., Uozumi, R., Ohno, S., Toi, M.: Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial. Brest Cancer Res Treat. 2021 Mar 25. doi: 10.1007/s10549-021-06184-w. Online ahead of print.

60.   Mimae, T., Tsutani, Y., Miyata, Y., Imai, K., Ito, H., Nakayama, H., Ikeda, N., Okada, M.: Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors. Ann Thorac Surg. 2020 May;109(5):1530-1536. (I)

61.   Zheng, YZ., Zhai, WY., Zhao, J., Luo, RX., Gu, WJ., Fu, SS., Wu, D., Yuan, LX., Jiang, W., Tsutani, Y., Liao, HY., Li, XQ.: Oncologic outcomes of lobectomy vs. segmentectomy in non-small cell lung cancer with clinical T1N0M0 stage: a literature review and meta-analysis. J Thorac Dis. 2020 Jun;12(6):3178-3187. (I)

62.   Shimoyama, R., Tsutani, Y., Wakabayashi, M., Katayama, H., Fukuda, H., Suzuki, K., Watanabe, SI.; Lung Cancer Surgical Study Group.: A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study). Jpn J Clin Oncol. 2020 Sep 28;50(10):1209-1213. (I)

63.   Kagimoto, A., Tsutani, Y., Handa, Y., Mimae, T., Miyata, Y., Okada, M.: Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma. Ann Surg Oncol. Epub 2020 Sep 18. (I)

64.   Kagimoto, A., Tsutani, Y., Okada, M.: ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection. Ann Surg Oncol. Epub 2020 Sep 23. (I)

65.   Kamigaichi,  A., Tsutani, Y., Okada, M.：Reply to Zhang et al.Eur J Cardiothorac Surg. 2020 Dec 21:ezaa419. doi: 10.1093/ejcts/ezaa419. Online ahead of print. (I)

66.   Kikkawa, T., Masui, Y., Toya, A., Ito, H., Hirano, T., Maeda, T., Ono, M., Murasaka, Y., Imamura, T., Matsumaru, T., Yamaguchi, M., Sugawara, M., Azhari, A., Song, H., Sasada, S., Iwata, A.: CMOS Gaussian Monocycle Pulse Transceiver for Radar-Based Microwave Imaging. IEEE Trans Biomed Circuits Syst. 2020 Dec; 14, 1333-1345, 2020. (I)

67.   Sueoka, S., Sasada, S., Masumoto, N., Emi, A., Kadoya, T., Okada, M.: Performance of dedicated breast positron emission tomography in the detection of small and low‑grade breast cancer. Breast Cancer Research and Treatment. 187(1): 125-133, 2021.

68.   Kagimoto, A., Mimura, T., Miyamoto, T., Nakashima, C., Yamashita, Y.:  Severity of emphysema as a prognosticator of resected early lung cancer: An analysis classified by Goddard score. Japanese Journal of Clinical Oncology. 2020; 50: 1043–1050.

69.   Kagimoto, A., Mimura, T., Hiraiwa, N., Yamashita, Y.: A survived case of penetrating neck injury with intrathoracic organ damage. Surgical Case Reports, 2021; 7: 78.

70.   川又あゆみ1)，曳野肇1)，槇野好成1)，村田陽子1)，高橋卓也2)，三浦弘資2)(1)松江赤十字病院乳腺外科(2)同病理診断科:乳腺線維腺腫内に発生した浸潤性小葉癌の１例．日本臨床外科学会雑誌第82巻3号.497-502.2021

71.   川又あゆみ，曳野肇，槇野好成，村田陽子:Oligometastasisと考える転移再発乳癌に対し局所療法が有効であった1例．癌と化学療法VOL.47(2020)別刷．2397-2399.2020.